Grace Alcaraz
Physician Assistant · Chicago, ILNPI 1356864698
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 97.0% of the total across 567 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 27 manufacturers, the largest accounting for just 19.3% — the pattern of someone who eats at a lot of different presentations. Among physician assistant clinicians in IL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 567 payments — averaging $17.87 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$2K
- Lilly USA, LLC$1K
- Novo Nordisk$1K
- Boehringer Ingelheim$1K
- AbbVie$704
- Pfizer$650
- plus $3K from 21 others
What the payments were for
- Food & beverage$9,83597%
- Gifts$3003%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 79 | $1,953 |
| Lilly USA, LLC | 78 | $1,239 |
| Novo Nordisk | 81 | $1,189 |
| Boehringer Ingelheim | 63 | $1,187 |
| AbbVie | 54 | $704 |
| Pfizer | 37 | $650 |
| Amgen | 33 | $456 |
| GSK | 20 | $390 |
| Bayer | 16 | $343 |
| Corcept Therapeutics | 19 | $340 |
| Novartis | 16 | $311 |
| Celltrion, Inc. | 1 | $300 |
| Redhill Biopharma Inc. | 29 | $286 |
| E.r. Squibb & Sons, L.L.C. | 13 | $242 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 6 | $101 |
| Johnson & Johnson | 5 | $89 |
| Biohaven Pharmaceutical Holding Company Ltd. | 4 | $81 |
| Merck | 3 | $53 |
| Biohaven Pharmaceuticals, Inc. | 1 | $50 |
| Hologic Sales And Service, LLC | 2 | $44 |
| Aurinia Pharma U.S., Inc. | 1 | $25 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 1 | $24 |
| Exact Sciences | 1 | $18 |
| Roche Diabetes Care, Inc. | 1 | $18 |
| Dexcom, Inc. | 1 | $18 |
| Sumitomo Pharma America, Inc. | 1 | $15 |
| Kowa Pharmaceuticals America, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Stoboclo$300
- FARXIGA$109
How this compares
$10,135 in reported general payments places this provider in the 95th percentile of 3,912 physician assistant providers in Illinois.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| FarxigaDapagliflozin Propanediol | 44 | $60,829 |
| JardianceEmpagliflozin | 41 | $57,657 |
| TradjentaLinagliptin | 26 | $30,147 |
| MyrbetriqMirabegron | 22 | $26,216 |
| EliquisApixaban | 14 | $24,274 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 37 | $23,519 |
| OzempicSemaglutide | 19 | $21,816 |
| Tresiba Flextouch U-100Insulin Degludec | 16 | $9,036 |
| Breo ElliptaFluticasone/Vilanterol | 13 | $8,861 |
| VascepaIcosapent Ethyl | 11 | $5,672 |
| ShingrixVaricella-Zoster Ge/As01b/Pf | 16 | $3,622 |
| Alcohol PadsAlcohol Antiseptic Pads | 15 | $2,967 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 88 | $2,401 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 23 | $2,333 |
| Atorvastatin Calcium | 252 | $2,280 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Boehringer IngelheimJardiance, Tradjenta | $1,187 | $87,80567 claims |
| AstraZenecaFarxiga | $1,953 | $60,82944 claims |
| GSKTrelegy Ellipta, Breo Ellipta, Shingrix | $390 | $36,00266 claims |
| PfizerEliquis | $650 | $24,27414 claims |
| Novo NordiskOzempic | $1,189 | $21,81619 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 3,912 physician assistant providers in Illinois.
Other physician assistant in Chicago
- Andrew MastroChicago$419K
- Renata BlockChicago$103K
- Margaret RomanoChicago$82K
- Christina StarksChicago$77K
- Kelly OconnorChicago$36K
- Christa CooperChicago$36K
- Audrey FenwickChicago$29K
- Amy LadewskiChicago$29K
- Lindsey KalhagenChicago$21K
- Jessica KarlChicago$18K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.